1-9 of 9
Jinsheng Weng
Close
Sort by
Journal Articles

Effect of Ivospemin and Difluoromethylornithine Polyamine Inhibitors on Viability of Myeloma Cell Lines

Abdur Rehman, Lubna Rehman, Krish Devnani, Cao Cuong Le, Chun-Yen Lin, Xiayoun Cheng, Fuliang Chu, Jinsheng Weng, Jingwei Liu, Sridevi Patchva, Shao-Qing Kuang, Jingjing Cao, Matthew Richard, Elizabeth Bruckheimer, Sattva S. Neelapu, Neeraj Y. Saini
Journal: Blood
Blood (2023) 142 (Supplement 1): 6589.
https://doi.org/10.1182/blood-2023-189595
Published: 2023
Journal Articles

Targeting B-Cell Malignancies with Anti-ROR1 CAR T-Cell Therapy

Jinsheng Weng, Cao Cuong Le, Yong Pan, Francesca Perutelli, Xiaoyun Cheng, Jingjing Cao, Owhofasa Agbedia, Shao-Qing Kuang, Jingwei Liu, Fuliang Chu, Sridevi Patchva, Neeraj Y. Saini, Sattva S. Neelapu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6827.
https://doi.org/10.1182/blood-2023-180028
Published: 2023
Journal Articles

Adoptive T-Cell Therapy with TCL1-Specific TCR for B-Cell Lymphomas

Jinsheng Weng, MD PhD, Kelsey Moriarty, BD, Yong Pan, Man Chun John MA, PhD, Rohit Mathur, PhD, Zheng Zhang, Hiroki Torikai, MD, Sourindra N Maiti, Fuliang Chu, PhD, Xiaoyun Cheng, Swathi Karri, Deepshika Medapalli, Laurence J N Cooper, MD PhD, R. Eric Davis, MD, Sattva S. Neelapu, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3488.
https://doi.org/10.1182/blood-2018-99-115424
Published: 2018
Journal Articles

Targeting CAR T Resistance Due to CD19 Loss with CD79b-Specific CAR T Cells in B-Cell Malignancies

Fuliang Chu, PhD, Jinsheng Weng, MD PhD, Shao-Qing Kuang, PhD, Xiaoyun Cheng, JingJing Cao, Jingwei Liu, MD, Swathi Karri, Adithi Reddy, Sattva S. Neelapu, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1662.
https://doi.org/10.1182/blood-2018-99-119009
Published: 2018
Journal Articles

PR1 Is Cross-Presented By Multiple Myeloma Cells in Patients and Renders Multiple Myeloma Susceptible to PR1-CTL and Anti-PR1/HLA-A2 Antibody

Gheath Alatrash, DO, PhD, Pariya Sukhumalchandra, BS, Mao Zhang, MPH, Celine Kerros, PhD, Anna Sergeeva, PhD, Amanda Cernosek, BS, Haroon Jakher, BS, Madhushree Zope, Rebecca Patenia, MS, Lisa St John, PhD, Alexander Perakis, BA, Karen Dwyer, PhD, Ken H. Young, MD PhD, Jinsheng Weng, PhD, Sijie Lu, PhD, Elizabeth A. Mittendorf, MD PhD, Larry W Kwak, MD PhD, Qing Ma, PhD, Jeffrey J. Molldrem, MD
Journal: Blood
Blood (2014) 124 (21): 2133.
https://doi.org/10.1182/blood.V124.21.2133.2133
Published: 2014
Journal Articles

Multiple Myeloma Cross-Presents Neutrophil Elastase and Proteinase 3 and Becomes Susceptible to PR1-Targeting Immunotherapy

Gheath Alatrash, DO, PhD, Pariya Sukhumalchandra, BS, Mao Zhang, MPH, Anna Sergeeva, PhD, Haroon Jakher, BS, Jinsheng Weng, Ph.D, Lisa S St. John, PhD, Kathryn Ruisaard, BS, Karen Clise-Dwyer, PhD, Sijie Lu, PhD, Jeffrey J. Molldrem, MD
Journal: Blood
Blood (2012) 120 (21): 4973.
https://doi.org/10.1182/blood.V120.21.4973.4973
Published: 2012
Journal Articles

TCL1: a shared tumor-associated antigen for immunotherapy against B-cell lymphomas

Jinsheng Weng, Seema Rawal, Fuliang Chu, Hyun Jun Park, Rakesh Sharma, David A. Delgado, Luis Fayad, Michelle Fanale, Jorge Romaguera, Amber Luong, Larry W. Kwak, Sattva S. Neelapu
Journal: Blood
Blood (2012) 120 (8): 1613–1623.
https://doi.org/10.1182/blood-2011-09-382838
Published: 2012
Includes: Supplemental data
Journal Articles

TCL1: A Shared Tumor-Associated Antigen for Immunotherapy Against B-Cell Lymphomas

Jinsheng Weng, Ph.D, Seema Rawal, PhD, Hyun Jun Park, Ph.D, Rakesh Sharma, Ph.D, Sattva S. Neelapu, MD
Journal: Blood
Blood (2011) 118 (21): 105.
https://doi.org/10.1182/blood.V118.21.105.105
Published: 2011
Journal Articles

Targeting Multiple Myeloma with Human Ig Light Chain Specific Cytotoxic T Lymphocytes

Jinsheng Weng, Soung-Chul Cha, Satoko Matsueda, Sattva Neelapu, MD, Larry W. Kwak, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3018.
https://doi.org/10.1182/blood.V116.21.3018.3018
Published: 2010